Xbrane Biopharma AB (publ) (7XB0)
Market Closed
20 Aug, 20:00
XSTU XSTU Primary €
0. 79
-0.01
-1.2563%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
€ 0.8
Previous Close Want to track 7XB0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xbrane Biopharma AB (publ) (7XB0) Statistics
Valuation metrics
Market Cap -
Enterprise value -28.28M
Trailing P/E (ttm) 12.05
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.04
Enterprise Value/Revenue -0.19
Enterprise Value/EBITDA 0.55
Overview
Shares outstanding 20.61M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 609
Average volume (90 days) 674
Price summary
52-Week low 0.79
52-Week high 2.92
Beta -
50-Day moving average 2.17
200-Day moving average 2.16
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:125
Last split Date 17 Oct 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.59%
Operating margin -0.21%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.23%
Income Statement
Revenue (ttm) 152.4M
Revenue per share (ttm) 9.28
Quarterly revenue growth (yoy) 0.91%
Gross profit (ttm) 89.55M
EBITDA -
Net income to common (ttm) 127.24M
Diluted EPS (ttm) 0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 56.88M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.03%
Book value per share (mrq) 26.7
Cash Flow
Cash flow statement 268.08M
Levered free cash flow (LFCF) 127.24M
